KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Enterprise Value (2016 - 2025)

Exact Sciences (EXAS) has disclosed Enterprise Value for 16 consecutive years, with -$964.7 million as the latest value for Q4 2025.

  • Quarterly Enterprise Value rose 7.06% to -$964.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$964.7 million through Dec 2025, up 7.06% year-over-year, with the annual reading at -$964.7 million for FY2025, 7.06% up from the prior year.
  • Enterprise Value for Q4 2025 was -$964.7 million at Exact Sciences, up from -$1.0 billion in the prior quarter.
  • The five-year high for Enterprise Value was -$213.0 million in Q2 2025, with the low at -$1.4 billion in Q1 2021.
  • Average Enterprise Value over 5 years is -$852.6 million, with a median of -$797.3 million recorded in 2022.
  • The sharpest move saw Enterprise Value plummeted 39.04% in 2024, then skyrocketed 77.5% in 2025.
  • Over 5 years, Enterprise Value stood at -$1.0 billion in 2021, then skyrocketed by 38.66% to -$632.1 million in 2022, then fell by 23.03% to -$777.6 million in 2023, then plummeted by 33.48% to -$1.0 billion in 2024, then grew by 7.06% to -$964.7 million in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$964.7 million, -$1.0 billion, and -$213.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.